Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.
about
Focus on renal congestion in heart failureUpdate on heart failure with preserved ejection fraction.Influenza infection and heart failure-vaccination may change heart failure prognosis?Beyond malignancy: the role of carbohydrate antigen 125 in heart failure.Predictors and outcomes of infection-related hospital admissions of heart failure patientsMicroinflammation factors in the common diseases of the heart and kidneysAssociation of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injuryIndoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.Associations Between Neutrophil Gelatinase Associated Lipocalin, Neutrophil-to-Lymphocyte Ratio, Atrial Fibrillation and Renal Dysfunction in Chronic Heart Failure.Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective.The prognostic significance of central hemodynamics in patients with cardiac amyloidosis.Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.Insights into RNA transcriptome profiling of cardiac tissue in obesity and hypertension conditions.Dynamic co-expression network analysis of lncRNAs and mRNAs associated with venous congestion.Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure.Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.Heart failure with preserved ejection fraction: a nephrologist-directed primer.Molecular models of the cardiorenal syndrome.Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome.Heart Failure and Kidney Disease.Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction.The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?Characterization of a Cardiorenal-like Syndrome in Aged Chimpanzees (Pan troglodytes).Natriuretic peptides system in the pulmonary tissue of rats with heart failure: potential involvement in lung edema and inflammation.Why is heart failure so important in the 21st century?
P2860
Q26769905-27E8619D-4C49-42CE-BD6D-BABA6F8715A2Q33640339-7C436C14-67DF-4CB8-833C-FDFB7B4A5254Q33708693-7D7E3AB4-99C3-439D-8235-188FEC0D1A22Q34255880-B94FA81F-0AE7-4C15-A88D-95404147CD4EQ34979546-AD46B8C6-B2A6-4E68-84E2-9E3AB8EEE9FEQ35025893-A6373BAB-025F-422C-AD2A-3761B47CBF47Q35204621-291909DC-AE38-41E9-9640-18D3E829BC65Q35891577-CBBF05DD-3B64-40B9-932C-8514BEBB733BQ36260141-2EF4C44D-2800-42B2-80BB-C9CD0E2F63A3Q37500020-958F5835-9A92-40E0-8C64-0579027219F5Q37524926-688C0348-6620-45A3-8833-DD1E0F24FA97Q37538163-EE02362A-34DB-458A-A08D-AA90920D23A9Q37633991-BC8A524A-D351-45B4-93F9-8AB7140ACCEDQ38076681-BEA9A8D0-B59A-4E3C-9B95-F01F3D872A40Q38124071-09B7090D-59FA-4F5F-913E-87B92CD308ECQ38165049-4139194E-2E97-4B12-921F-9D84319F7A8FQ38173317-8FBE5738-35DF-452E-BF87-4C1885846EABQ38267844-C4E3D3ED-02C0-4773-8117-454497F26005Q38444737-BC4D47BD-F74F-40BD-9BDF-1E580ECDB9B6Q38695069-A7C0DE59-CE96-4FE2-B265-8B47174BCDA6Q38703008-D5F119C1-57CA-42BB-8772-0A9AEDF2B22AQ38826590-6CC45F8E-3A7B-4293-B1A8-CD3E45A901BFQ39276030-16B8A5D4-E81E-45CF-A615-5919FD9C67F9Q39301622-7C2C3C02-64EF-414F-B088-DC7DF3F94DA4Q46899838-99049119-D1B4-4F0E-8C3C-88D27BDDB36FQ46927699-BB7F9CE5-4363-4E9E-BEC5-FF277A6267AFQ47134639-C941E130-F419-483F-8F94-550A7170830EQ47437642-54833DAE-FD9F-45DB-8DFF-C04683A72236Q47548712-73049726-B237-43A7-B6C0-E20A7774B3A5Q48172048-9BC60F55-3E6E-429F-85C9-096B7993575CQ49620885-2DDB4B27-5609-43D2-A4B5-268B31128E86Q52589926-63F459C1-A557-4102-9981-E5AE188C191EQ52820698-2B7230CC-7FE6-42CF-AA13-EBC47166F729Q54945407-C1134807-9F0D-4822-ABA2-E93AF885C084Q58371147-1E847096-85CD-4E44-9940-75D91645C0FD
P2860
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@en
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@nl
type
label
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@en
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@nl
prefLabel
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@en
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@nl
P2093
P2860
P1476
Inflammatory activation: cardi ...... with the cardiorenal syndrome.
@en
P2093
Anjali Ganda
Ante Harxhi
Duygu Onat
Jeffrey Lin
Julia E Iyasere
Paolo C Colombo
P2860
P2888
P304
P356
10.1007/S10741-011-9261-3
P50
P577
2012-03-01T00:00:00Z